ESR1 and breast carcinoma: To test the effect of JQ1 on breast cancer cells, two TNBC (MDA-MB-231 and BT549) and two ER+ (MCF7 and T47D) breast cancer cell lines were treated with increasing concentrations of JQ1 for 48 hours.